The IPO Market Is Roaring Back in 2026 — and the Biggest Deals May Still Be Ahead
Medline's record IPO reopened the new-issue window. With SpaceX, OpenAI and Databricks reportedly weighing listings, 2026 could top 2021.
New listings, from S-1 filing to first-day trade and beyond. We track the pipeline, the pricing and — more usefully — how debuts perform once the first-day pop fades.
Medline's record IPO reopened the new-issue window. With SpaceX, OpenAI and Databricks reportedly weighing listings, 2026 could top 2021.